Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer:: A new standard in patient care?

被引：4
|
作者：
Gonzalez Martin, A. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Med Oncol Serv, Madrid 28034, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2007年 / 9卷 / 07期
关键词：
D O I：
10.1007/s12094-007-0077-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：409 / 411
页数：3
相关论文
共 50 条
  • [1] Intraperitoneal chemotherapy for optimally debulked advanced ovarian cancer: A new standard in patient care?
    A. González Martín
    [J]. Clinical and Translational Oncology, 2007, 9 : 409 - 411
  • [2] Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer
    Gray, Heidi J.
    Shah, Chirag A.
    Swensen, Ron E.
    Tamirni, Hisham K.
    Goff, Barbara A.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : 340 - 344
  • [3] Optimally Debulked Stage III Ovarian Cancer Intraperitoneal or Intravenous Chemotherapy?
    Friedlander, Michael
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S20 - S23
  • [4] INTRAPERITONEAL CHEMOTHERAPY IN PATIENTS WITH OPTIMALLY DEBULKED OVARIAN CANCER - THE WESTMEAD HOSPITAL EXPERIENCE
    Girgis, C.
    Brand, A.
    Wain, G.
    Hogg, R.
    Harnett, P.
    Lindemann, K.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 765 - 765
  • [5] Intraperitoneal chemotherapy is appropriate first line therapy for patients with optimally debulked ovarian cancer
    Markman, M
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 38 (03) : 171 - 175
  • [6] Life after 172: Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer
    Gray, H. J.
    Shah, C. A.
    Swensen, R. E.
    Tamimi, H. K.
    Goff, B. A.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S26 - S27
  • [7] Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?
    Le, T.
    Latifah, H.
    Jolicoeur, L.
    Weberpals, J.
    Faught, W.
    Hopkins, L.
    Fung, M. Fung Kee
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 121 (03) : 451 - 454
  • [8] Toxicity of intraperitoneal chemotherapy and risk factors for severe toxicity in optimally debulked ovarian cancer patients
    Koo, Yu-Jin
    Lim, Kyung-Taek
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2015, 54 (03): : 275 - 279
  • [9] Is there a survival benefit associated with intraperitoneal chemotherapy after neoadjuvant chemotherapy for optimally debulked epithelial ovarian cancer patients?
    Song, M.
    Vogel, R. Isaksson
    Rivard, C.
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 145 : 101 - 101
  • [10] A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
    Suidan, Rudy S.
    Clair, Caryn M. St.
    Lee, Stephen J.
    Barlin, Joyce N.
    Roche, Kara C. Long
    Tanner, Edward J.
    Sonoda, Yukio
    Barakat, Richard R.
    Zivanovic, Oliver
    Chi, Dennis S.
    [J]. GYNECOLOGIC ONCOLOGY, 2014, 134 (03) : 468 - 472
12345